CYCLIN B1 EXPRESSION IN MOTHERS OF DOWN SYNDROME VERSUS EUPLOID CHILDREN
Open Access
- 29 February 2024
- journal article
- Published by Andijan State Medical Institute in Международный журнал научной педиатрии
- Vol. 3 (2) , 479-484
Abstract
Introduction. Down Syndrome (DS) is the most common chromosomopathy. Cyclin B1 is a regulatory protein involved in mitosis. The aim was to determine the cyclin B1 relative expression in mothers of DS patients. Methods. In this cross-sectional study, mononuclear cells of peripheral blood were obtained from 40 mothers of confirmed DS patients and 40 mothers of euploid patients, between 2019-2021. Demographic variables and cyclin B1 messenger RNA (mRNA) with real-time polymerase chain reaction (qPCR) were analyzed. The cases of DS mothers were compared to the relative expression of euploid group. Results. cyclin B1 mean relative expression by RT-PCR showed a significant difference between the group of mothers of DS children and mothers of euploid children (p < 0.05). The expression of the cyclin B1 was lower than the mean of mothers with euploid patients. Previously, it has been reported that the cyclin B1 down expression should accelerate telomere shortening in DS patients. Therefore, it would be advisable to recategorize the maternal age-related risk factor. Conclusion. Cyclin B1 may be a cost-effective biomarker in reproductive age women to present a DS case not associated with chronological age.Keywords
This publication has 19 references indexed in Scilit:
- Prevalence and risk factors for Down syndrome: A hospital‐based single‐center study in Western MexicoAmerican Journal of Medical Genetics Part A, 2019
- Association between telomere length and chromosome 21 nondisjunction in the oocyteHuman Genetics, 2015
- Cyclin D1 Again Caught in the Act: Dyrk1a Links G1 and Neurogenesis in Down SyndromeEBioMedicine, 2015
- DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down SyndromeEBioMedicine, 2015
- Mosaicism for trisomy 21: A reviewAmerican Journal of Medical Genetics Part A, 2014
- Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humansMolecular Nutrition & Food Research, 2013
- Cyclin B in Mouse Oocytes and Embryos: Importance for Human Reproduction and Aneuploidy2012
- Aberrant epigenetic landscape in intellectual disability2012
- Telomere length is associated with types of chromosome 21 nondisjunction: a new insight into the maternal age effect on Down syndrome birthHuman Genetics, 2010
- RETRACTED: Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and heartsBiochemical and Biophysical Research Communications, 2008